Henry Ford Hospital, Detroit
Reduction of cardiac fibrosis may not benefit cardiac function
Published in Cardiovascular Business Week, June 29th, 2004
According to recent research from the United States, "Pressure-overload left ventricular hypertrophy (LVH) is characterized by an increase in myocyte size and fibrosis. However, it is not clear how each of these components affects hypertensive heart disease (HHD)."
"We have shown in two different rat models of hypertension that cardiac fibrosis can be reduced with N-acetyl-seryl-aspartyl-lysylproline (Ac-SDKP), an antifibrotic peptide normally present in mammals," wrote O.H. Cingolani and colleagues, Henry Ford...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- ARYx Therapeutics Inc.
Pharmaceutical R&D company completes $55M Series D financing - Business and Finance
Psychiatric Solutions completes purchase of inpatient psychiatric facilities - Cardiac Science, Inc.
AED distribution pact signed for People's Republic of China - Edwards Lifesciences Corp.
John Cardis elected to board at cardiovascular disease company - Gamma Medica, Inc.
Cardiac gating subsystem available for X-SPECT preclinical imaging system - Medco Health Solutions, Inc.
Brand medications preferred over generics for serious conditions, survey shows - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
